MOHAP (The Ministry of Health and Prevention) has announced the reduction of the prices of select medicines following a collaboration with the international pharmaceutical company, Sanofi Aventis.
The move comes as part of the Ministry’s periodic reviews conducted in cooperation with global organizations to re-price medicines to support patients and improve access to affordable medicines.
Dr. Amin Hussein Al Amiri, Assistant Under-Secretary for Public Health Policy and Licensing and Vice Chairman of the Higher committee for Drug Pricing and Registration, said that the price adjustments were done in pursuant to Ministerial Decree No. 1400 of 2017 issued by Dr. Abdul Rahman bin Mohammad bin Nasser Al Owais, Minister of Health and Prevention and in accordance with the Federal Law No. 01 of 1972 on the functions of ministries and the empowerment of ministers, Federal Law No. 04 of 1983 on the profession of pharmacy and pharmaceutical institutions and Decree of the Ministers Cabinet No. 140 of 2013 on determining the prices of medicines and calculating new exchange rates for foreign currency, along with the amendments of the aforementioned laws.
He assured that the Ministry will continuously coordinate with companies and distributors and monitor the medicine supply in the country to ensure availability and avoid drug shortage.
The Ministry also supervises pharmaceutical companies to guarantee compliance with proper storage standards and distribution process to prevent any damage and ensure optimal patient care. It will publish on its website and local newspapers a list of medicines with their new prices to prevent any violations and to benefit all patients in the UAE.
Post Your Comments